Cell/Gene Tx channel feed – Endpoints News

Cell/Gene Tx channel feed

Early snapshot of Adverum's eye gene therapy sparks concern about vision loss

6 years ago

Italian gene therapy player draws new investor from China for its answer to CAR-T relapses

6 years ago

A new player jumps into the heated race for a sickle cell cure, with help from Google's GV

6 years ago

London's 4BIO Capital unveils first close of $150M fund dedicated to advanced therapies

6 years ago

Plotting clinical entry, James Wilson's gene therapy startup brings in billionaire for $110M Series B

6 years ago

Nkarta maps out clinical, manufacturing plans for CAR-NK following $114M round led by Samsara

6 years ago

Syncona dives deep into dry AMD R&D, upping Gyroscope bet to $100M

6 years ago

Immatics scores $75M upfront in TCR deal with Celgene as interest in tech burgeons

6 years ago

Adaptimmune pledges $312M for Noile-Immune's T cell boosting tech in drive to deliver on TCR promise

6 years ago

Cadre of gene-editing biotechs rally against altering DNA that could affect future generations

6 years ago

Biotech targeting rare heart mutation with gene therapy scores $11M in Series A haul

6 years ago

Plugging in the last piece to its gene therapy puzzle, AskBio acquires Scottish synthetic promoter company

6 years ago

Questions pile up for Novartis as senators call on FDA to take action

6 years ago

Bayer is going all in on next-gen stem cell biotech BlueRock, buying out Versant and founders for $600M

6 years ago

Part procedure, part drug: Robert Ang joins Siddhartha Mukherjee in pioneering a new type of cell engineering

6 years ago

Joining Chang and Belldegrun, Rafael Amado takes a leading R&D post in the next big cell therapy revolution

6 years ago

PACT Pharma says it's perfected the tech to select neoantigens for personalized therapy — now onto the clinic

6 years ago

Keen to stay out front in cell therapy, Gilead's Kite builds its own viral vector manufacturing operations

6 years ago

Takeda's translational cell therapy group revs up for a race to the clinic with off-the-shelf CAR-T

6 years ago

Microcap Capricor soars on interim PhII DMD data showing functional benefit for older patients

6 years ago

Supercharging CAR-T with cancer vaccine, MIT team spotlights some new tech underpinning Darrell Irvine's startup

6 years ago

Fresh out of Eli Lilly, Christi Shaw surfaces as Daniel O'Day's new CEO at CAR-T pioneer Kite

6 years ago

Billions on the line: BioMarin bustles past enthused rival, planning to launch world’s first hemophilia A gene therapy

6 years ago

The chief scientist at German/US biotech hybrid Immatics is moving to the helm. Here's his to-do list

6 years ago

First page Previous page 50 51 525354 55 56 Next page Last page